$117.27 (0.248%)

Volume: 1.217M

Closed: Jan 27, 2023

Hollow Logo Score: 4.863
BioMarin Pharmaceutical Inc. Stock
$117.27 (0.248%)

Volume: 1.217M

Closed: Jan 27, 2023

Score Hollow Logo 4.863
NASDAQ:BMRN

BioMarin Pharmaceutical Inc. Stock Price (Quote)

$117.27 ( 0.248% ) Friday, 27th Jan 2023

Range Low Price High Price Comment
30 days $100.52 $117.77 Friday, 27th Jan 2023 BMRN stock ended at $117.27. This is 0.248% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 0.82% from a day low at $116.81 to a day high of $117.77.
90 days $80.53 $117.77
52 weeks $70.73 $117.77

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
2023-01-27 $117.00 $117.77 $116.81 $117.27 1 217 204
2023-01-26 $116.00 $117.11 $115.03 $116.98 1 336 524
2023-01-25 $114.60 $116.59 $114.39 $116.03 2 450 322
2023-01-24 $111.45 $114.02 $111.26 $113.82 1 202 216
2023-01-23 $110.40 $111.55 $110.20 $111.45 1 173 358
2023-01-20 $109.47 $111.03 $109.29 $110.75 1 338 400
2023-01-19 $110.47 $110.47 $109.10 $109.20 1 148 300
2023-01-18 $111.31 $112.05 $110.33 $110.69 1 107 348
2023-01-17 $111.55 $112.99 $111.02 $111.75 1 554 900
2023-01-13 $112.25 $114.80 $111.87 $112.72 1 582 120
2023-01-12 $110.50 $113.65 $110.01 $113.57 1 723 544
2023-01-11 $111.23 $112.70 $109.14 $111.15 1 699 156
2023-01-10 $107.26 $111.97 $106.99 $111.40 2 864 771
2023-01-09 $109.83 $110.25 $105.95 $107.10 2 526 703
2023-01-06 $108.17 $109.29 $106.90 $108.71 2 205 800
2023-01-05 $107.00 $107.59 $105.77 $106.86 1 794 348
2023-01-04 $103.69 $106.93 $102.26 $106.92 2 710 984
2023-01-03 $103.00 $103.33 $100.52 $100.61 1 025 099
2022-12-30 $101.92 $103.57 $100.95 $103.49 889 346
2022-12-29 $101.87 $103.45 $101.67 $102.44 794 578
2022-12-28 $101.98 $103.10 $101.30 $101.74 904 491
2022-12-27 $104.50 $104.85 $102.03 $102.16 760 711
2022-12-23 $105.01 $105.56 $103.87 $104.34 696 038
2022-12-22 $104.61 $105.70 $103.99 $105.66 1 335 845
2022-12-21 $105.94 $107.08 $104.53 $104.62 1 457 763
2022-12-20 $105.92 $106.75 $105.56 $106.30 997 223
2022-12-19 $108.63 $108.63 $105.81 $106.61 1 225 988
2022-12-16 $107.73 $108.92 $107.13 $108.63 2 537 038
2022-12-15 $108.00 $109.56 $106.81 $108.61 1 614 617
2022-12-14 $106.93 $109.25 $106.51 $108.38 1 672 054
2022-12-13 $107.08 $107.91 $106.55 $107.08 1 765 332
2022-12-12 $102.25 $106.35 $102.25 $106.26 1 856 434
2022-12-09 $104.23 $104.46 $102.28 $102.33 815 513
2022-12-08 $103.99 $104.62 $103.17 $104.39 723 024
2022-12-07 $101.09 $103.94 $101.09 $103.69 1 319 198
2022-12-06 $102.97 $103.44 $101.17 $102.22 889 357
2022-12-05 $105.00 $105.34 $103.25 $103.53 994 347
2022-12-02 $103.00 $106.72 $102.75 $105.56 2 220 168
2022-12-01 $100.71 $103.06 $99.29 $103.02 2 013 886
2022-11-30 $98.51 $101.28 $97.85 $100.98 2 493 125
2022-11-29 $99.01 $99.56 $97.00 $97.12 1 304 257
2022-11-28 $97.25 $100.30 $96.52 $98.66 2 591 319
2022-11-25 $97.46 $98.43 $96.31 $96.92 727 779
2022-11-23 $95.09 $99.74 $94.91 $97.79 4 635 440
2022-11-22 $88.99 $91.63 $88.01 $91.18 1 620 250
2022-11-21 $88.67 $88.86 $87.98 $88.51 734 460
2022-11-18 $88.04 $88.76 $87.65 $88.13 501 999
2022-11-17 $85.66 $87.92 $85.63 $87.11 639 146
2022-11-16 $86.69 $86.69 $85.51 $86.23 613 362
2022-11-15 $85.30 $87.44 $84.78 $86.60 855 042

Hot Stocks To Watch:

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT